HOUSE_OVERSIGHT_024654.jpg
1.6 MB
Extraction Summary
0
People
4
Organizations
0
Locations
1
Events
0
Relationships
3
Quotes
Document Information
Type:
Investment report / scientific overview
File Size:
1.6 MB
Summary
This document is page 18 of a 'Cannabis Investment Report' published by Ackrell Capital, LLC in December 2017. It provides a scientific overview of the Human Endocannabinoid System, specifically detailing the functions and locations of CB1 and CB2 receptors in the body. It bears the Bates stamp 'HOUSE_OVERSIGHT_024654', indicating it was part of a document production for a congressional investigation, though the specific page contains no direct references to Jeffrey Epstein or his associates.
Organizations (4)
| Name | Type | Context |
|---|---|---|
| Ackrell Capital, LLC |
Creator of the Cannabis Investment Report
|
|
| FINRA |
Ackrell Capital is a member
|
|
| SIPC |
Ackrell Capital is a member
|
|
| House Oversight Committee |
Inferred from Bates stamp 'HOUSE_OVERSIGHT_024654'
|
Timeline (1 events)
Key Quotes (3)
"The human endocannabinoid system consists of nervous and immune system receptors involved in regulating health and physiological functions."Source
HOUSE_OVERSIGHT_024654.jpg
Quote #1
"The physiological effects of cannabis consumption are believed to be primarily the result of THC, CBD and other cannabinoids bonding with the body’s endocannabinoid receptors"Source
HOUSE_OVERSIGHT_024654.jpg
Quote #2
"Although medical research on cannabinoids is nascent, cannabis is currently being used to manage many conditions, including anxiety, depression, inflammation, insomnia, nausea, neural disorders and pain."Source
HOUSE_OVERSIGHT_024654.jpg
Quote #3
Full Extracted Text
Complete text extracted from the document (2,159 characters)
ACKRELL
CAPITAL
Cannabis Investment Report | December 2017
CAPITAL
Cannabis Investment Report | December 2017
■ The Human Endocannabinoid System
The human endocannabinoid system consists of nervous and immune system receptors involved in
regulating health and physiological functions. There are two types of endocannabinoid receptors, CB1
and CB2 receptors, which are located in the brain and in other organs, tissues and glands throughout
the human body. The human body actively regulates variables related to appetite, immune response,
memory, mood, pain, sleep and other functions by naturally creating compounds known as “endo-
cannabinoids” and delivering them to these receptors. The following illustration depicts the human
endocannabinoid system and the location of CB1 and CB2 receptors.
The human endocannabinoid system consists of nervous and immune system receptors involved in
regulating health and physiological functions. There are two types of endocannabinoid receptors, CB1
and CB2 receptors, which are located in the brain and in other organs, tissues and glands throughout
the human body. The human body actively regulates variables related to appetite, immune response,
memory, mood, pain, sleep and other functions by naturally creating compounds known as “endo-
cannabinoids” and delivering them to these receptors. The following illustration depicts the human
endocannabinoid system and the location of CB1 and CB2 receptors.
Human Endocannabinoid System
CB1 Receptors
CB2 Receptors
Immune Cells
CB2 Receptors
Immune Cells
CB1
Brain
Lungs
Vascular system
Muscles
Gastrointestinal tract
Reproductive organs
Brain
Lungs
Vascular system
Muscles
Gastrointestinal tract
Reproductive organs
CB2
Spleen
Bones
Skin
Glial cells
Spleen
Bones
Skin
Glial cells
CB1 and CB2
Immune system
Liver
Bone marrow
Pancreas
Brain stem
Immune system
Liver
Bone marrow
Pancreas
Brain stem
The physiological effects of cannabis consumption are believed to be primarily the result of THC,
CBD and other cannabinoids bonding with the body’s endocannabinoid receptors and the consequent
impact on functions regulated by the endocannabinoid system. As scientists gain a deeper understand-
ing of the human endocannabinoid system, they are beginning to explore the application of cannabi-
noids to a broad range of medical conditions and ailments. Although medical research on cannabinoids
is nascent, cannabis is currently being used to manage many conditions, including anxiety, depression,
inflammation, insomnia, nausea, neural disorders and pain.
CBD and other cannabinoids bonding with the body’s endocannabinoid receptors and the consequent
impact on functions regulated by the endocannabinoid system. As scientists gain a deeper understand-
ing of the human endocannabinoid system, they are beginning to explore the application of cannabi-
noids to a broad range of medical conditions and ailments. Although medical research on cannabinoids
is nascent, cannabis is currently being used to manage many conditions, including anxiety, depression,
inflammation, insomnia, nausea, neural disorders and pain.
CB1 and CB2 Receptors
CB1 and CB2 endocannabinoid receptors, which are found on cell surfaces throughout the body, are
believed to be more numerous than any other cellular receptor signaling system in the human body.
The CB1 receptors are located primarily in the brain, central nervous system and other tissues; these
receptors play a modulatory role in memory, mood, sleep, appetite and pain sensation. The CB2 recep-
CB1 and CB2 endocannabinoid receptors, which are found on cell surfaces throughout the body, are
believed to be more numerous than any other cellular receptor signaling system in the human body.
The CB1 receptors are located primarily in the brain, central nervous system and other tissues; these
receptors play a modulatory role in memory, mood, sleep, appetite and pain sensation. The CB2 recep-
18
© 2017 Ackrell Capital, LLC | Member FINRA / SIPC
© 2017 Ackrell Capital, LLC | Member FINRA / SIPC
HOUSE_OVERSIGHT_024654
Discussion 0
No comments yet
Be the first to share your thoughts on this epstein document